• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CHP2 参与非小细胞肺癌的发生发展及患者不良预后

Involvement of CHP2 in the Development of Non-Small Cell Lung Cancer and Patients' Poor Prognosis.

机构信息

Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, People's Republic of China.

出版信息

Appl Immunohistochem Mol Morphol. 2020 Oct;28(9):678-686. doi: 10.1097/PAI.0000000000000818.

DOI:10.1097/PAI.0000000000000818
PMID:33030853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7664967/
Abstract

The present study aimed to investigate the expression levels and clinical significance of the calcineurin B homologous protein 2 (CHP2) in non-small cell lung cancer (NSCLC), and to study its effects on biological characteristics of NSCLC cells. Tumor and adjacent samples were collected from 196 NSCLC patients. Western blot analysis was used to detect the expression levels of the CHP2 in 8 pairs of NSCLC fresh tissues and 4 NSCLC cell lines. Immunohistochemical analysis was used to detect the expression of the CHP2 in 188 additional pairs of NSCLC wax block tissues. The data indicated that the expression levels of the CHP2 in the paraffin and fresh tissues of NSCLC were significantly higher than those of the adjacent tissues. According to the histo-score, univariate and multivariate analysis indicated that a high expression level of CHP2 was an important factor affecting the 5-year survival rate of NSCLC patients. After knocking down the expression of CHP2 in NSCLC cell lines, the proliferative, migratory, and invasive activities of NSCLC-CHP2 cells were decreased which were assessed by Western blotting, Cell Counting Kit-8, and transwell and wound-healing assays. In conclusion, the data demonstrated that CHP2 was highly expressed in NSCLC and that it could promote the development of NSCLC, suggesting its potential application for the therapy of NSCLC.

摘要

本研究旨在探讨钙调神经磷酸酶同源蛋白 2(CHP2)在非小细胞肺癌(NSCLC)中的表达水平及其临床意义,并研究其对 NSCLC 细胞生物学特性的影响。收集了 196 例 NSCLC 患者的肿瘤和相邻样本。Western blot 分析用于检测 8 对 NSCLC 新鲜组织和 4 种 NSCLC 细胞系中 CHP2 的表达水平。免疫组织化学分析用于检测 188 对额外的 NSCLC 蜡块组织中 CHP2 的表达。数据表明,CHP2 在 NSCLC 石蜡和新鲜组织中的表达水平明显高于相邻组织。根据组织评分,单因素和多因素分析表明,CHP2 高表达是影响 NSCLC 患者 5 年生存率的重要因素。在 NSCLC 细胞系中敲低 CHP2 的表达后,通过 Western blot、细胞计数试剂盒-8 检测和 Transwell 和划痕愈合实验评估 NSCLC-CHP2 细胞的增殖、迁移和侵袭活性均降低。总之,数据表明 CHP2 在 NSCLC 中高度表达,并且可以促进 NSCLC 的发展,提示其在 NSCLC 治疗中的潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7af/7664967/f2741dc20c99/pai-28-678-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7af/7664967/fcf753b1d920/pai-28-678-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7af/7664967/4dcb8558c42e/pai-28-678-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7af/7664967/508bc34d83b3/pai-28-678-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7af/7664967/f2741dc20c99/pai-28-678-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7af/7664967/fcf753b1d920/pai-28-678-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7af/7664967/4dcb8558c42e/pai-28-678-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7af/7664967/508bc34d83b3/pai-28-678-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7af/7664967/f2741dc20c99/pai-28-678-g004.jpg

相似文献

1
Involvement of CHP2 in the Development of Non-Small Cell Lung Cancer and Patients' Poor Prognosis.CHP2 参与非小细胞肺癌的发生发展及患者不良预后
Appl Immunohistochem Mol Morphol. 2020 Oct;28(9):678-686. doi: 10.1097/PAI.0000000000000818.
2
Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.NKD1 的下调会增加非小细胞肺癌的侵袭潜力,并与不良预后相关。
BMC Cancer. 2011 May 20;11:186. doi: 10.1186/1471-2407-11-186.
3
Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion.长链非编码 RNA SNHG15 表明非小细胞肺癌预后不良,并促进细胞增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2018 May;22(9):2671-2679. doi: 10.26355/eurrev_201805_14963.
4
Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.Orai1的过表达介导细胞增殖,并与人类非小细胞肺癌的不良预后相关。
Int J Clin Exp Pathol. 2015 May 1;8(5):5080-8. eCollection 2015.
5
TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.TMEM229A 通过抑制 ERK 通路抑制非小细胞肺癌进展。
Oncol Rep. 2021 Aug;46(2). doi: 10.3892/or.2021.8127. Epub 2021 Jun 29.
6
Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway.PKMYT1的过表达预示着预后不良,并通过激活Notch信号通路增强非小细胞肺癌的增殖和肿瘤发生。
Eur Rev Med Pharmacol Sci. 2019 May;23(10):4210-4219. doi: 10.26355/eurrev_201905_17925.
7
LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.长链非编码RNA HOXA-AS2通过调控微小RNA-216a-5p促进非小细胞肺癌的恶性进展。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):264-273. doi: 10.26355/eurrev_201908_18656.
8
MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line.微小 RNA-373 通过靶向人非小细胞肺癌 A549 细胞系中的 BRF2 抑制细胞增殖和侵袭。
Cancer Res Treat. 2018 Jul;50(3):936-949. doi: 10.4143/crt.2017.302. Epub 2017 Oct 12.
9
Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.HJURP 的敲低抑制了 Wnt/β-连环蛋白信号通路,从而抑制非小细胞肺癌细胞的增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2019 May;23(9):3847-3856. doi: 10.26355/eurrev_201905_17812.
10
Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.长链非编码RNA PVT1表达增加促进非小细胞肺癌的肿瘤发生。
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6929-35. eCollection 2014.

引用本文的文献

1
Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis.宫颈腺样腺癌:系统评价和荟萃分析。
Arch Gynecol Obstet. 2021 Aug;304(2):317-327. doi: 10.1007/s00404-021-06077-9. Epub 2021 May 25.

本文引用的文献

1
Calcineurin homologous protein isoform 2 supports tumor survival via the sodium hydrogen exchanger isoform 1 in non-small cell lung cancer.钙调神经磷酸酶同源蛋白亚型2通过钠氢交换体亚型1支持非小细胞肺癌中的肿瘤存活。
Tumour Biol. 2020 Jul;42(7):1010428320937863. doi: 10.1177/1010428320937863.
2
Advanced Non-Small Cell Lung Cancer: Sequencing Agents in the EGFR-Mutated/ALK-Rearranged Populations.晚期非小细胞肺癌:EGFR突变/ALK重排人群中的序贯治疗药物
Am Soc Clin Oncol Educ Book. 2019 Jan;39:e187-e197. doi: 10.1200/EDBK_237821. Epub 2019 May 17.
3
Expression of cornulin in oral premalignant lesions.
角蛋白 16 在口腔癌前病变中的表达。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Jun;127(6):526-534. doi: 10.1016/j.oooo.2019.02.003. Epub 2019 Feb 13.
4
Gene Expression Classification of Lung Adenocarcinoma into Molecular Subtypes.肺腺癌的基因表达分类成分子亚型。
IEEE/ACM Trans Comput Biol Bioinform. 2020 Jul-Aug;17(4):1187-1197. doi: 10.1109/TCBB.2019.2905553. Epub 2019 Mar 18.
5
PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.PIK3CA 突变在导管原位癌和相邻浸润性乳腺癌中的作用。
Endocr Relat Cancer. 2019 May;26(5):471-482. doi: 10.1530/ERC-19-0019.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
CHP2 Promotes Cell Proliferation in Breast Cancer via Suppression of FOXO3a.CHP2 通过抑制 FOXO3a 促进乳腺癌细胞增殖。
Mol Cancer Res. 2018 Oct;16(10):1512-1522. doi: 10.1158/1541-7786.MCR-18-0157. Epub 2018 Jul 2.
8
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
9
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.现行世卫组织指南与免疫组织化学标志物在非小细胞肺癌(NSCLC)分类中的关键作用:从靶向治疗到免疫治疗。
Semin Cancer Biol. 2018 Oct;52(Pt 1):103-109. doi: 10.1016/j.semcancer.2017.11.019. Epub 2017 Nov 26.
10
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.癌症的分子靶向治疗:核医学医师指南
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):41-54. doi: 10.1007/s00259-017-3695-3. Epub 2017 Apr 10.